ASH Data Bring UniQure Closer To Filing Hemophilia B Gene Therapy

Late-Breaking Data Suggest Activity At Level Needed For Approval

 
• By Alaric DeArment
  
Hemophilia_525478450_1200.jpg
UniQure will present topline Phase III data at ASH • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Blood and Clotting

More from Therapy Areas